Umit Tapan, MD

Assistant Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Dr. Umit Tapan is an Assistant Professor of Medicine at Chobanian and Avedisian School of Medicine and practicing Thoracic Oncologist at Boston Medical Center. His clinical interests are Non-small cell lung cancer, Small cell lung cancer, Mesothelioma, Immunotherapy, Targeted therapy/Precision Medicine. His research interests include Circulating tumor DNA, Gut microbiome and Cancer Immunotherapy, Racial Disparities in Cancer Care and Outcomes.

Dr. Tapan completed his fellowship in Hematology & Oncology at Boston Univesity Medical Center, in which he was Chief Fellow in Hematology & Oncology. Dr. Tapan completed his internship and residency at Steward Carney Hospital. He earned his medical degree from Hacettepe University School of Medicine, Ankara, Turkey.

Publications

  • Published 4/15/2025

    Shah MV, Solem CT, Bell KF, Aziez A, Sun X, Du M, Du EX, Yang H, Wang H, Hua Q, Tapan U. Real-World Maintenance Treatment Patterns Among Patients with Advanced Non-Small Cell Lung Cancer. Adv Ther. 2025 Jun; 42(6):2782-2796. PMID: 40232624.

    Read at: PubMed

  • Published 3/10/2025

    Radwan A, Jani CT, Al Omari O, Patel M, Burns L, Mackay Z, Li L, Mahdaviani K, Davidson A, Weinberg J, Everett PC, Suzuki K, Mak KS, Kulke MH, Tapan U. The impact of immune-related adverse events on survival outcomes in a racially diverse population, with a focus on non-Hispanic Black patients. Oncologist. 2025 Mar 10; 30(3). PMID: 39603266.

    Read at: PubMed

  • Published 9/9/2024

    Murphy JF, Amin LB, Celikkaleli ST, Brown HE, Tapan U. Disparities in cancer care in individuals with severe mental illness: A narrative review. Cancer Epidemiol. 2024 Dec; 93:102663. PMID: 39255550.

    Read at: PubMed

  • Published 12/29/2023

    Burns L, Tukachinsky H, Raskina K, Huang RSP, Schrock AB, Sands J, Kulke MH, Oxnard GR, Tapan U. Real-World comprehensive genomic profiling data for diagnostic clarity in pulmonary Large-Cell neuroendocrine carcinoma. Lung Cancer. 2024 Feb; 188:107454. PMID: 38159439.

    Read at: PubMed

  • Published 12/12/2023

    Dudipala H, Burns L, Jani CT, Radwan A, Al Omari O, Patel M, Kilic S, Zhao J, Mak K, Suzuki K, Tapan U. Disparities in Lung Cancer Clinical Trial Discussion and Enrollment at a Safety Net Hospital. Community Health Equity Res Policy. 2023 Dec 12; 2752535X231221394. PMID: 38087807.

    Read at: PubMed

Other Positions

  • Member, BU-BMC Cancer Center
    Boston University
  • Member, Evans Center for Interdisciplinary Biomedical Research
    Boston University